Literature DB >> 11321187

Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.

D Krametter1, G Niederwieser, A Berghold, G Birnbaum, S Strasser-Fuchs, H P Hartung, J J Archelos.   

Abstract

Humoral immune responses to Chlamydia pneumoniae (C. pneumoniae) were studied in paired sera and cerebrospinal fluid (CSF) of patients with definite multiple sclerosis (MS) and other inflammatory and non-inflammatory neurological diseases. Seropositivity was not significantly different between these groups. However, C. pneumoniae-specific IgG titers were significantly higher in CSF of MS than in controls. Sixteen out of 52 seropositive MS patients (30.8%) showed intrathecal synthesis of C. pneumoniae-specific IgG but only one of 43 seropositive controls (2.3%). In MS, this was strongly associated with intrathecal synthesis of polyclonal IgG in 13/16 patients. However, these elevated C. pneumoniae antibody titers in CSF did not significantly correlate with disease duration, disease course, clinical or MRI disease activity, disability or presence of oligoclonal IgG in MS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11321187     DOI: 10.1177/135245850100700103

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

Review 2.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

3.  Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Carmine Tamborino; Silva Seraceni; Maria Rosaria Tola; Enrico Granieri; Carlo Contini
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

4.  Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association.

Authors:  Stylianos Chatzipanagiotou; Constantinos Tsakanikas; Maria Anagnostouli; Michalis Rentzos; Anastassios Ioannidis; Chryssoula Nicolaou
Journal:  Mol Diagn       Date:  2003

Review 5.  Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?

Authors:  Mickael Bonnan
Journal:  Front Neurol       Date:  2014-03-11       Impact factor: 4.003

Review 6.  Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.

Authors:  Kyla A McKay; Vivian Kwan; Thomas Duggan; Helen Tremlett
Journal:  Biomed Res Int       Date:  2015-01-31       Impact factor: 3.411

Review 7.  Infectious causes of multiple sclerosis.

Authors:  Donald H Gilden
Journal:  Lancet Neurol       Date:  2005-03       Impact factor: 44.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.